AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 29771390 — intervention group
Group type: COMPARATOR
Intervention: SFI vs Control
Number of subjects: 481
Study 28825930 — intervention group
Group type: EXPERIMENTAL
Intervention: Mannequin-based simulation
Number of subjects: 50
Study 28825930 — intervention group
Group type: COMPARATOR
Intervention: Computer screen-based simulator
Number of subjects: 50
Study 26510263 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 40
Study 26510263 — intervention group
Group type: COMPARATOR
Intervention: Isoflurane
Number of subjects: 40
Study 23308026 — intervention group
Group type: EXPERIMENTAL
Intervention: Explicit instructions to older siblings to supervise younger siblings and prevent specific risky behaviors
Number of subjects: 0
Study 23308026 — intervention group
Group type: COMPARATOR
Intervention: No explicit instructions to older siblings
Number of subjects: 0
Study 22105254 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral misoprostol (75 micrograms)
Number of subjects: 350
Study 22105254 — intervention group
Group type: COMPARATOR
Intervention: Intravenous oxytocin
Number of subjects: 350
Study 19199870 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivastigmine
Number of subjects: 63
Study 19199870 — intervention group
Group type: EXPERIMENTAL
Intervention: Galantamine
Number of subjects: 63
Study 19199870 — intervention group
Group type: EXPERIMENTAL
Intervention: Donepezil
Number of subjects: 63
Study 16169654 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanol-based adhesive (Single Bond) on dry enamel
Number of subjects: 40
Study 16169654 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanol-based adhesive (Single Bond) on wet enamel
Number of subjects: 40
Study 16169654 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetone-based adhesive (Prime&Bond NT) on dry enamel
Number of subjects: 40
Study 16169654 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetone-based adhesive (Prime&Bond NT) on wet enamel
Number of subjects: 40
Study 16169654 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-etching adhesive (Clearfil SE Bond)
Number of subjects: 40
Study 16169654 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetone-based adhesives (in general)
Number of subjects: 40
Study 16169654 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanol-based adhesives (in general)
Number of subjects: 40
Study 15351166 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.05 mmol/kg body weight of Gd-DTPA
Number of subjects: 94
Study 15351166 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.10 mmol/kg body weight of Gd-DTPA
Number of subjects: 94
Study 15351166 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.15 mmol/kg body weight of Gd-DTPA
Number of subjects: 94
Study 11524328 — intervention group
Group type: EXPERIMENTAL
Intervention: BIS monitoring
Number of subjects: 469
Study 11524328 — intervention group
Group type: COMPARATOR
Intervention: Control (non-BIS monitoring)
Number of subjects: 469
Study 9416950 — intervention group
Group type: EXPERIMENTAL
Intervention: Irbesartan
Number of subjects: 0
Study 9416950 — intervention group
Group type: COMPARATOR
Intervention: Enalapril (up to 40 mg)
Number of subjects: 0
Study 9416950 — intervention group
Group type: COMPARATOR
Intervention: Enalapril
Number of subjects: 0
Study 8387087 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral instructions indicating blood pressure would increase
Number of subjects: 120
Study 8387087 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral instructions indicating blood pressure would decrease
Number of subjects: 120
Study 8387087 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral instructions indicating no change in blood pressure
Number of subjects: 120
Study 8387087 — intervention group
Group type: COMPARATOR
Intervention: No instructions (Control group)
Number of subjects: 120
Study 3030946 — intervention group
Group type: EXPERIMENTAL
Intervention: Trimethoprim-polymyxin B sulfate cream
Number of subjects: 100
Study 3030946 — intervention group
Group type: COMPARATOR
Intervention: Fusidic acid cream
Number of subjects: 100
Study 29102959 — intervention group
Group type: EXPERIMENTAL
Intervention: TRC101 (1.5, 3, or 4.5 g twice daily or 6 g once daily)
Number of subjects: 135
Study 29102959 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 135
Study 27666887 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic ultrasound guided group (n=57)
Number of subjects: 156
Study 27666887 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic group (n=54)
Number of subjects: 156
Study 27666887 — intervention group
Group type: COMPARATOR
Intervention: Open resection group (n=45)
Number of subjects: 156
Study 24933221 — intervention group
Group type: EXPERIMENTAL
Intervention: Tongue Diagnosis System (TDS)
Number of subjects: 60
Study 22243034 — intervention group
Group type: EXPERIMENTAL
Intervention: Specific acupoints of the stomach meridian (Group A)
Number of subjects: 712
Study 22243034 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture of non‐acupoints (Group E)
Number of subjects: 712
Study 22243034 — intervention group
Group type: EXPERIMENTAL
Intervention: Other acupuncture groups (Group B, C, D)
Number of subjects: 712
Study 22243034 — intervention group
Group type: EXPERIMENTAL
Intervention: Itopride (Group F)
Number of subjects: 712
Study 22243034 — intervention group
Group type: EXPERIMENTAL
Intervention: All acupuncture groups
Number of subjects: 712
Study 22243034 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A vs other acupuncture groups
Number of subjects: 712
Study 20805450 — intervention group
Group type: EXPERIMENTAL
Intervention: Multivitamin use during adjuvant chemotherapy
Number of subjects: 1038
Study 20805450 — intervention group
Group type: EXPERIMENTAL
Intervention: Multivitamin use reported 6 months after completion of adjuvant chemotherapy
Number of subjects: 1038
Study 20805450 — intervention group
Group type: EXPERIMENTAL
Intervention: Consistent multivitamin use during and following adjuvant therapy
Number of subjects: 1038
Study 20805450 — intervention group
Group type: EXPERIMENTAL
Intervention: Increasing number of tablets or duration of use before cancer diagnosis
Number of subjects: 1038
Study 20805450 — intervention group
Group type: EXPERIMENTAL
Intervention: Multivitamin use
Number of subjects: 1038
Study 18575017 — intervention group
Group type: EXPERIMENTAL
Intervention: CPAP treatment for 3 days
Number of subjects: 42
Study 18575017 — intervention group
Group type: COMPARATOR
Intervention: Control group C1 (mild or moderate SAS, not treated with CPAP)
Number of subjects: 42
Study 18575017 — intervention group
Group type: COMPARATOR
Intervention: Control group C2 (healthy subjects)
Number of subjects: 42
Study 16203942 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle-focused, fitness-oriented gym classes (treatment group)
Number of subjects: 50
Study 16203942 — intervention group
Group type: COMPARATOR
Intervention: Standard gym classes (control group)
Number of subjects: 50
Study 11804987 — intervention group
Group type: EXPERIMENTAL
Intervention: Eptifibatide
Number of subjects: 1134
Study 11804987 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1134
Study 10088935 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled carbachol
Number of subjects: 166
Study 10088935 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 166
Study 7491818 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunotherapy with Mycobacterium w vaccine
Number of subjects: 93
Study 7491818 — intervention group
Group type: COMPARATOR
Intervention: MDT + placebo injections (Control)
Number of subjects: 93
Study 2110437 — intervention group
Group type: EXPERIMENTAL
Intervention: Fleroxacin 200 mg for 10 days
Number of subjects: 62
Study 2110437 — intervention group
Group type: EXPERIMENTAL
Intervention: Fleroxacin 400 mg for 10 days
Number of subjects: 62
Study 2110437 — intervention group
Group type: EXPERIMENTAL
Intervention: Fleroxacin 600 mg for 10 days
Number of subjects: 62
Study 1147869 — intervention group
Group type: EXPERIMENTAL
Intervention: d-amphetamine (10 mg)
Number of subjects: 30
Study 1147869 — intervention group
Group type: EXPERIMENTAL
Intervention: secobarbital (100 mg)
Number of subjects: 30
Study 1147869 — intervention group
Group type: COMPARATOR
Intervention: placebo (no drug)
Number of subjects: 30
Study 31600243 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral B-12 2μg/day alone
Number of subjects: 39
Study 31600243 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral B-12 2μg/day with multiple micronutrients (UNIMAPP formula + 20gm milk powder)
Number of subjects: 39
Study 28470154 — intervention group
Group type: EXPERIMENTAL
Intervention: Strength based I‐change smoking cessation program
Number of subjects: 97
Study 28470154 — intervention group
Group type: COMPARATOR
Intervention: General smoking cessation program
Number of subjects: 97
Study 28470154 — intervention group
Group type: COMPARATOR
Intervention: Control group (no program)
Number of subjects: 97
Study 25488587 — intervention group
Group type: EXPERIMENTAL
Intervention: BIAsp BID+Sit
Number of subjects: 582
Study 25488587 — intervention group
Group type: EXPERIMENTAL
Intervention: BIAsp QD+Sit
Number of subjects: 582
Study 25488587 — intervention group
Group type: COMPARATOR
Intervention: BIAsp BID
Number of subjects: 582
Study 23752669 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-energy diet (LED) (800‐1000 kcal/d) for 8 weeks followed by 8 weeks of reintroduction of normal food intake (1200 kcal/d)
Number of subjects: 60
Study 23752669 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-energy diet (LED)
Number of subjects: 60
Study 23752669 — intervention group
Group type: COMPARATOR
Intervention: Control group (ordinary healthy foods)
Number of subjects: 60
Study 21921362 — intervention group
Group type: EXPERIMENTAL
Intervention: Vildagliptin (50 mg/day for 8 weeks, titrated to a maximum of 100 mg/day)
Number of subjects: 51
Study 21921362 — intervention group
Group type: COMPARATOR
Intervention: Control group (no vildagliptin administered)
Number of subjects: 51
Study 19555469 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma dehydroepiandrosterone sulfate (DHEAS)
Number of subjects: 1172
Study 19555469 — intervention group
Group type: EXPERIMENTAL
Intervention: Total testosterone
Number of subjects: 1172
Study 19555469 — intervention group
Group type: EXPERIMENTAL
Intervention: Calculated free testosterone
Number of subjects: 1172
Study 19555469 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual variants or haplotypes in AR, ESR2, PGR, CYP19 genes
Number of subjects: 1172
Study 19555469 — intervention group
Group type: EXPERIMENTAL
Intervention: AR CAG repeat
Number of subjects: 1172
Study 16449473 — intervention group
Group type: EXPERIMENTAL
Intervention: Lamotrigine
Number of subjects: 66
Study 16449473 — intervention group
Group type: EXPERIMENTAL
Intervention: Inositol
Number of subjects: 66
Study 16449473 — intervention group
Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 66
Study 15290663 — intervention group
Group type: EXPERIMENTAL
Intervention: Mayo regimen
Number of subjects: 150
Study 15290663 — intervention group
Group type: EXPERIMENTAL
Intervention: de Gramont regimen
Number of subjects: 150
Study 11409513 — intervention group
Group type: EXPERIMENTAL
Intervention: Open ventriculoperitoneal (VP) shunt
Number of subjects: 54
Study 11409513 — intervention group
Group type: COMPARATOR
Intervention: Conventional shunts
Number of subjects: 54
Study 9210712 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant therapy
Number of subjects: 0
Study 8427432 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam (1 mg/mL) administered until desired sedation achieved (max 5 mL)
Number of subjects: 69
Study 8427432 — intervention group
Group type: COMPARATOR
Intervention: Diazepam (2.5 mg/mL) administered until desired sedation achieved (max 5 mL)
Number of subjects: 69
Study 3116290 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous branched chain amino acid (BCAA) diet (60-80 g/day, BCAA content 51%, energy 2000 kcal/day)
Number of subjects: 8
Study 3116290 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasogastric (NG) branched chain amino acid (BCAA) diet (amino acids 58 g, BCAA 43%, oligopeptides 19.5 g, energy 2000 kcal/day)
Number of subjects: 8
Study 3116290 — intervention group
Group type: COMPARATOR
Intervention: Both groups (iv and NG)
Number of subjects: 8
Study 29420152 — intervention group
Group type: EXPERIMENTAL
Intervention: Ischemic conditioning (IC)
Number of subjects: 10
Study 29420152 — intervention group
Group type: COMPARATOR
Intervention: Sham
Number of subjects: 10
Study 26782793 — intervention group
Group type: EXPERIMENTAL
Intervention: Rescue Board (RB)
Number of subjects: 35
Study 26782793 — intervention group
Group type: COMPARATOR
Intervention: No Equipment (NE)
Number of subjects: 35
Study 26782793 — intervention group
Group type: EXPERIMENTAL
Intervention: Fins
Number of subjects: 35
Study 26782793 — intervention group
Group type: EXPERIMENTAL
Intervention: Fins and Rescue Tube
Number of subjects: 35
Study 25759404 — intervention group
Group type: EXPERIMENTAL
Intervention: Tianeptine (12.5 mg)
Number of subjects: 0
Study 25759404 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 24158142 — intervention group
Group type: EXPERIMENTAL
Intervention: Coloured zirconia cores with shade A2 and corresponding veneering ceramics (ICE Ceramic, GC Initial Zr, IPS e.max Ceram)
Number of subjects: 240
Study 24158142 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-coloured zirconia cores with corresponding veneering ceramics (ICE Ceramic, GC Initial Zr, IPS e.max Ceram)
Number of subjects: 240
Study 24158142 — intervention group
Group type: COMPARATOR
Intervention: Control group (high noble alloys Esteticor Plus veneered with ceramic VM 13, n=16)
Number of subjects: 240
Study 20870871 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-balloon catheter with 3% polidocanol foam
Number of subjects: 20
Study 20870871 — intervention group
Group type: COMPARATOR
Intervention: Follow-up at six months
Number of subjects: 20
Study 20870871 — intervention group
Group type: COMPARATOR
Intervention: Follow-up at twelve months
Number of subjects: 20
Study 20870871 — intervention group
Group type: EXPERIMENTAL
Intervention: Side effects reported
Number of subjects: 20
Study 18266541 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediation
Number of subjects: 109
Study 18266541 — intervention group
Group type: COMPARATOR
Intervention: Litigation
Number of subjects: 109
Study 16865041 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 mg/kg MPH
Number of subjects: 34
Study 16865041 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study 15568935 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxygenation-index images obtained from near-infrared imaging at wavelengths 690, 750, 788, and 856 nm.
Number of subjects: 0
Study 15568935 — intervention group
Group type: COMPARATOR
Intervention: Edge-corrected near-infrared optical mammograms.
Number of subjects: 0
Study 11251616 — intervention group
Group type: EXPERIMENTAL
Intervention: Parenting intervention programme for adolescent mothers and their infants
Number of subjects: 0
Study 11251616 — intervention group
Group type: COMPARATOR
Intervention: Control group (implied)
Number of subjects: 0
Study 9418516 — intervention group
Group type: EXPERIMENTAL
Intervention: Behaviour modification techniques by professionals through eight home visits
Number of subjects: 0
Study 8219559 — intervention group
Group type: EXPERIMENTAL
Intervention: Bypass surgery (BP)
Number of subjects: 263
Study 8219559 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous transluminal angioplasty (PTA)
Number of subjects: 263
Study 8219559 — intervention group
Group type: COMPARATOR
Intervention: Overall (BP and PTA)
Number of subjects: 263
Study 2890364 — intervention group
Group type: EXPERIMENTAL
Intervention: Tubocurarine 0.05 mg kg‐1
Number of subjects: 50
Study 2890364 — intervention group
Group type: COMPARATOR
Intervention: Physiological saline
Number of subjects: 50
Study 2890364 — intervention group
Group type: EXPERIMENTAL
Intervention: Vecuronium 0.012 mg kg‐1
Number of subjects: 50
Study 31775831 — intervention group
Group type: EXPERIMENTAL
Intervention: Family intervention consisting of eight sessions of 90 min duration
Number of subjects: 132
Study 31775831 — intervention group
Group type: COMPARATOR
Intervention: Control group receiving 2 h of psychoeducation
Number of subjects: 132
Study 27436226 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-expansion during treatment
Number of subjects: 239
Study 26373711 — intervention group
Group type: EXPERIMENTAL
Intervention: Boston University approach to Psychiatric Rehabilitation (BPR)
Number of subjects: 225
Study 26373711 — intervention group
Group type: COMPARATOR
Intervention: Care As Usual (CAU)
Number of subjects: 225
Study 24095984 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5% NaF/5% TMP
Number of subjects: 10
Study 24095984 — intervention group
Group type: COMPARATOR
Intervention: 5% NaF
Number of subjects: 10
Study 24095984 — intervention group
Group type: COMPARATOR
Intervention: Placebo (no F or TMP)
Number of subjects: 10
Study 24095984 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5% NaF
Number of subjects: 10
Study 22152238 — intervention group
Group type: EXPERIMENTAL
Intervention: TIPS combined with embolization of gastric coronary veins
Number of subjects: 122
Study 22152238 — intervention group
Group type: COMPARATOR
Intervention: TIPS alone
Number of subjects: 122
Study 19200379 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 17267927 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.2 g eicosapentaenoic acid plus 0.9 g decosahexaenoic acid (n=22)
Number of subjects: 49
Study 17267927 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n=27)
Number of subjects: 49
Study 15078794 — intervention group
Group type: EXPERIMENTAL
Intervention: ACHIEVE paclitaxel-coated stent
Number of subjects: 1043
Study 15078794 — intervention group
Group type: COMPARATOR
Intervention: ML PENTA stent
Number of subjects: 1043
Study 11332334 — intervention group
Group type: EXPERIMENTAL
Intervention: Candesartan cilexetil 8-16 mg once daily
Number of subjects: 395
Study 11332334 — intervention group
Group type: COMPARATOR
Intervention: Enalapril 10-20 mg once daily
Number of subjects: 395
Study 9754981 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical betaxolol (0.5%) administered 1-2 hours before surgery
Number of subjects: 131
Study 9754981 — intervention group
Group type: COMPARATOR
Intervention: Placebo administered 1-2 hours before surgery
Number of subjects: 131
Study 9754981 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical betaxolol (0.5%) administered 48 hours before surgery
Number of subjects: 131
Study 7871080 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine placebo (C+)
Number of subjects: 50
Study 7871080 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine placebo (C-)
Number of subjects: 50
Study 7871080 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol placebo (A+)
Number of subjects: 50
Study 7871080 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol placebo (A-)
Number of subjects: 50
Study 7871080 — intervention group
Group type: COMPARATOR
Intervention: No-treatment control group
Number of subjects: 50
Study 3128139 — intervention group
Group type: EXPERIMENTAL
Intervention: Ro 15‐1788 at a dosage of 0.2 mg (2 ml)
Number of subjects: 30
Study 3128139 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 29223633 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative irrigation with chlorhexidine for seven days
Number of subjects: 100
Study 29223633 — intervention group
Group type: COMPARATOR
Intervention: Postoperative chlorhexidine mouth rinse for seven days
Number of subjects: 100
Study 27567361 — intervention group
Group type: EXPERIMENTAL
Intervention: IVF‐SET
Number of subjects: 602
Study 27567361 — intervention group
Group type: EXPERIMENTAL
Intervention: IVF‐MNC
Number of subjects: 602
Study 27567361 — intervention group
Group type: COMPARATOR
Intervention: IUI‐OS
Number of subjects: 602
Study 24429540 — intervention group
Group type: EXPERIMENTAL
Intervention: Crystalline amino acid mixture with protein intakes of 0.1, 0.3, 0.6, 0.9, 1.2, 1.5, or 1.8 g · kg⁻¹ · d⁻¹
Number of subjects: 6
Study 24429540 — intervention group
Group type: EXPERIMENTAL
Intervention: Crystalline amino acid mixture
Number of subjects: 6
Study 22633817 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary intervention group (IG) - instructed to reduce intake of insoluble dietary fibres and lactose
Number of subjects: 130
Study 22633817 — intervention group
Group type: COMPARATOR
Intervention: Standard care group (SC) - instructed to continue normal diet
Number of subjects: 130
Study 19889805 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron-fortified rice (micronized ferric pyrophosphate)
Number of subjects: 175
Study 19889805 — intervention group
Group type: COMPARATOR
Intervention: Iron drops (control)
Number of subjects: 175
Study 18477493 — intervention group
Group type: EXPERIMENTAL
Intervention: Mifepristone capsule (75 mg)
Number of subjects: 18
Study 18477493 — intervention group
Group type: COMPARATOR
Intervention: Mifepristone tablet (75 mg)
Number of subjects: 18
Study 15618262 — intervention group
Group type: EXPERIMENTAL
Intervention: CAST (Childhood Asperger Syndrome Test)
Number of subjects: 1925
Study 12469154 — intervention group
Group type: COMPARATOR
Intervention: 24‐h protracted IV infusion of 5‐FU at 320 mg/m(2)/day for 5 days (CIV group)
Number of subjects: 38
Study 12469154 — intervention group
Group type: EXPERIMENTAL
Intervention: 10‐min bolus IV infusion of 5‐FU at 320 mg/m(2)/day for 5 days (BIV group)
Number of subjects: 38
Study 10915400 — intervention group
Group type: EXPERIMENTAL
Intervention: Clarithromycin suspension 7.5 mg/kg twice daily for 5 days
Number of subjects: 528
Study 10915400 — intervention group
Group type: COMPARATOR
Intervention: Penicillin V suspension 13.3 mg/kg three times daily for 10 days
Number of subjects: 528
Study 9012219 — intervention group
Group type: EXPERIMENTAL
Intervention: Innovative respiratory muscle training apparatus
Number of subjects: 30
Study 9012219 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 30
Study 1686562 — intervention group
Group type: EXPERIMENTAL
Intervention: GR122311X 196 mg b.d.
Number of subjects: 0
Study 1686562 — intervention group
Group type: EXPERIMENTAL
Intervention: GR122311X 391 mg b.d.
Number of subjects: 0
Study 1686562 — intervention group
Group type: EXPERIMENTAL
Intervention: GR122311X 782 mg b.d.
Number of subjects: 0
Study 1686562 — intervention group
Group type: COMPARATOR
Intervention: 150 mg ranitidine b.d.
Number of subjects: 0
Study 1686562 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 6662004 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin 0.5% solution eyedrops
Number of subjects: 0